Mylan v. Research Corp. Techs. Mylan Pharms. Inc. v. Research Corp. Techs., Inc. (Fed. Cir. 2019) Patent claims non-obvious Read about it on Patently-O and PatentDocs… PatentDocs Post Patently-O Post Share: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Click to print (Opens in new window) Print Petitioner Must Prove Injury to Have Standing to Appeal an IPR DecisionDateJanuary 11, 2017In relation toCase LawGilead Wins Another Sofosbuvir Challenge: U. Minnesota v. GileadDateMarch 13, 2023In relation toCase LawAmerigen and Alembic petition to join Mylan’s IPR arguing that patent claims covering Toviaz® are obvious over Detrol®DateSeptember 7, 2016In relation toCase Law